Nextgen Biomed Ltd

    Nextgen Biomed Ltd

    TTASE:NXGN
    - -
    ILA
    - -
    - -
    Nextgen Biomed Ltd
    TASE:NXGN
    (Tel Aviv Stock Exchange)

    Recent

    price

    - -

    P/E

    ratio

    - -

    div

    yld

    - -

    ROIC.AI

    ILS
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Revenue per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Basic EPS, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Free Cash Flow per Basic Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Dividend per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Book Value per Share
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Tangible Book Value per Share
    - -
    1
    1
    3
    5
    5
    5
    5
    7
    7
    7
    - -
    Basic Weighted Avg Shares
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Sales/Revenue/Turnover
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Operating Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Depreciation Expense
    -8
    -5
    -4
    -2
    -1
    -1
    -1
    -1
    -3
    -9
    -14
    -5
    Net Income, GAAP
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Effective Tax Rate (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Profit Margin (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Working Capital
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    LT Debt
    - -
    -1
    2
    5
    4
    2
    1
    7
    21
    12
    -1
    -2
    Total Equity
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Invested Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Capital (%)
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    Return on Common Equity (%)

    Capital Structure

    ILS

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Working Capital

    ILS

    •

    in mil. unless spec.
    No data availableFinancial data will appear here once available

    Growth Rates

    ILS

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    47.46%
    137.89%
    151.79%
    Free Cash Flow
    - -
    - -
    - -
    Net Income, GAAP
    23.25%
    67.94%
    -65.53%
    Sales/Revenue/Turnover
    - -
    - -
    - -
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    ILS

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    No data availableFinancial data will appear here once available

    Quarterly Earnings Per Share

    ILS

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    No data availableFinancial data will appear here once available

    Quarterly Dividends Per Share

    ILS

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    No data availableFinancial data will appear here once available
    Similar Companies
    Business